Pharmacologic marrow purging in murine T cell leukemia

  • Copelan E
  • Johnson S
  • Grever M
  • et al.
N/ACitations
Citations of this article
N/AReaders
Mendeley users who have this article in their library.

Abstract

Deoxycoformycin in combination with deoxyadenosine was used to purge 6C3HED malignant T cells from murine marrow in vitro. Adenosine deaminase activity of 6C3HED cells was ablated by incubation with 10(- 6) mol/L deoxycoformycin (dCF). During a 12-hour incubation with 10(-6) mol/L dCF and 10(-4) mol/L deoxyadenosine, tumor cells sequentially accumulated dATP, became depleted of NAD followed by ATP, then died. More than 5 logs of 6C3HED cells were killed as measured by survival of mice injected with treated tumor cells. Identical incubation of 5 x 10(6) marrow cells did not interfere with rescue of syngeneic lethally irradiated mice. Long-term survival was demonstrated in 12 of 14 mice that received marrow that had been contaminated with 5% 6C3HED cells, incubated with deoxycoformycin and deoxyadenosine, then used to rescue lethally irradiated mice. This murine model provides information not available from in vitro assays and may be useful in the development of strategies to purge malignant T cells from marrow.

Cite

CITATION STYLE

APA

Copelan, E., Johnson, S., Grever, M., Sheridan, J., & Tutschka, P. (1988). Pharmacologic marrow purging in murine T cell leukemia. Blood, 71(6), 1656–1661. https://doi.org/10.1182/blood.v71.6.1656.bloodjournal7161656

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free